You watched
Catalog
Client
Currency:
+380 66 708 47 52
Our location:
Ternopil city
Phones:
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Viewed
1
Wishlist
0
Compare
0
Contacts

Glemont chewable tablets 5 mg blister No. 30

SKU: an-61678
0
All about product
Description
Specification
Reviews 0
Questions0
new
Glemont chewable tablets 5 mg blister No. 30
Glemont chewable tablets 5 mg blister No. 30
Glemont chewable tablets 5 mg blister No. 30
Glemont chewable tablets 5 mg blister No. 30
Glemont chewable tablets 5 mg blister No. 30
Glemont chewable tablets 5 mg blister No. 30
In Stock
463.23 грн.
Buy this product in 1 click:
Active ingredient:Montelukast
Adults:Children's release form
ATC code:R RESPIRATORY SYSTEM ACTIVATORY MEDICINES; R03 MEDICINES FOR THE TREATMENT OF OBSTRUCTIVE AIRWAY DISEASES; R03D OTHER MEDICINES FOR SYSTEMIC USE IN OBSTRUCTIVE AIRWAY DISEASES; R03D C Leukotriene receptor antagonists; R03D C03 Montelukast
Country of manufacture:India
Diabetics:Can
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Glemont chewable tablets 5 mg blister No. 30
463.23 грн.
Description

Montelukast 5 mg chewable tablets are recommended for children aged 6 to 14 years:

as an additional treatment for bronchial asthma in patients with mild to moderate persistent asthma not adequately controlled by inhaled corticosteroids, and in patients with inadequate clinical control of asthma with short-acting β-agonists used as needed; as an alternative treatment to low doses of inhaled corticosteroids for patients with mild persistent asthma who have not had a recent serious asthma attack requiring corticosteroids, and for those patients who are intolerant to inhaled corticosteroids; as a prophylaxis of asthma in which exercise-induced bronchospasm is the dominant component; for the relief of symptoms of seasonal and perennial allergic rhinitis.

Composition

Active ingredient: montelukast;

1 tablet contains montelukast sodium equivalent to montelukast 5 mg;

Excipients: microcrystalline cellulose, mannitol (E 421), croscarmellose sodium, hydroxypropylcellulose, magnesium stearate, aspartame (E 951), cherry flavoring.

Contraindication

Hypersensitivity to the components of the drug.

Method of application

The drug should be used by children under adult supervision.

Children aged 2 to 5 years. For patients with asthma and allergic rhinitis (seasonal and perennial), the recommended dose is 1 chewable tablet of 4 mg once daily.

Children aged 6 to 14 years. For patients with asthma and allergic rhinitis (seasonal and perennial), the recommended dose is 1 chewable tablet of 5 mg once daily.

For the treatment of asthma, the chewable tablet should be taken in the evening 1 hour before or 2 hours after a meal. For the relief of symptoms of allergic rhinitis, the time of administration should be selected individually.

Application features

Pregnant women

Montelukast should be used during pregnancy only if considered absolutely necessary.

Children

Do not use in children under 2 years of age.

Drivers

The drug is intended for use in children.

Overdose

There is no information on the treatment of overdose with montelukast. In chronic asthma studies, montelukast has been administered at doses up to 200 mg/day to adult patients for 22 weeks, and in short-term studies, up to 900 mg/day for approximately one week, with no clinically significant adverse reactions.

Treatment is symptomatic.

Side effects

Infections and infestations: upper respiratory tract infections; Nervous system disorders: headache; Gastrointestinal disorders: abdominal pain; General disorders: thirst.

Interaction

Montelukast can be administered with other drugs for the prevention or long-term treatment of asthma. In drug-drug interaction studies, the recommended clinical dose of montelukast had no clinically significant effect on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (ethinylestradiol/norethindrone 35/1), terfenadine, digoxin, and warfarin.

Storage conditions

Store in a dry place, protected from light, at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life - 2 years.

Specifications
Characteristics
Active ingredient
Montelukast
Adults
Children's release form
ATC code
R RESPIRATORY SYSTEM ACTIVATORY MEDICINES; R03 MEDICINES FOR THE TREATMENT OF OBSTRUCTIVE AIRWAY DISEASES; R03D OTHER MEDICINES FOR SYSTEMIC USE IN OBSTRUCTIVE AIRWAY DISEASES; R03D C Leukotriene receptor antagonists; R03D C03 Montelukast
Country of manufacture
India
Diabetics
Can
Dosage
5 мг
Drivers
It is impossible.
For allergies
Can
For children
From 6 to 14 years old
Form
Chewable tablets
Method of application
Inside, solid
Nursing
It is impossible.
Pregnant
It is impossible.
Primary packaging
blister
Producer
Glenmark
Quantity per package
30 pcs
Trade name
Glemont
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

You are watched
463.23 грн.